Sajad Amiri

Dr. Sajad Amiri

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2025 in IEEE Access
Verified
Journal Article
Open access
MSMohammad R. Salmanpour
Mohammad R. Salmanpour
MAMorteza Alizadeh
Morteza Alizadeh
GMGhazal Mousavi
Ghazal Mousavi
SSSaba Sadeghi
Saba Sadeghi
Sajad AmiriSajad Amiri
Sajad Amiri
IHIlker Hacihaliloglu
Ilker Hacihaliloglu
This study evaluates metrics for tasks such as classification, regression, clustering, correlation analysis, statistical tests, segmentation, and image-to-image (I2I) translation in medical imaging domains. Metrics were compared across Python libraries, R packages, and Matlab functions to assess their consistency and highlight discrepancies. The findings underscore the need for a unified roadmap to standardize metrics, ensuring reliable and reproducible ML evaluations across platforms. This study examined a wide range of evaluation metrics across various tasks in medical imaging and found only some to be consistent across platforms, such as Accuracy, Balanced Accuracy, Cohens Kappa, F-beta Score, MCC, Geometric Mean, AUC, and Log Loss in binary classification; Accuracy, Cohens Kappa, and F-beta Score in multi-class classification; MAE, MSE, RMSE, MAPE, Explained Variance, Median AE, MSLE, and Huber in regression; Davies-Bouldin Index and Calinski-Harabasz Index in clustering; Pearson, Spearman, Kendall’s Tau, Mutual Information, Distance Correlation, Bicor, Percbend, Shepherd, and Partial Correlation in correlation analysis; Paired t-test, Chi-Square Test, ANOVA, Kruskal-Wallis Test, Shapiro-Wilk Test, Welch’s t-test, and Bartlett’s test in statistical tests; Accuracy, Precision, and Recall in 2D segmentation; Accuracy in 3D segmentation; MAE, MSE, RMSE, and R-Squared in 2D-I2I translation; and MAE, MSE, and RMSE in 3D-I2I translation. Given observation of discrepancies in a number of metrics (e.g. precision, recall and F1 score in binary classification, WCSS in clustering, and multiple statistical tests, amongst multiple metrics), this study concludes that ML evaluation metrics require standardization and recommends that future research use consistent metrics for different tasks to effectively compare ML techniques and solutions.

26 January 2026 in Inventions
Verified
Journal Article
Open access
PDF file
Sajad AmiriSajad Amiri
Sajad Amiri
STShahram Taeb
Shahram Taeb
SGSara Gharibi
Sara Gharibi
SDSetareh Dehghanfrad
Setareh Dehghanfrad
SMSomayeh Sadat Mehrnia
Somayeh Sadat Mehrnia
MSMohammad R. Salmanpour
Mohammad R. Salmanpour
Gadolinium-based contrast agents (GBCAs) are vital for glioma imaging yet pose safety, cost, and accessibility issues; predicting contrast enhancement from non-contrast MRI via machine learning (ML) provides a safer, economical alternative, as enhancement indicates tumor aggressiveness and informs treatment planning. However, scanner and population variability hinder robust model selection. To overcome this, a stability-aware framework was developed to identify reproducible ML pipelines for predicting glioma contrast enhancement across multicenter cohorts. A total of 1367 glioma cases from four TCIA datasets (UCSF-PDGM, UPENN-GB, BRATS-Africa, BRATS-TCGA-LGG) were analyzed, using non-contrast T1-weighted images as input and deriving enhancement status from paired post-contrast T1-weighted images; 108 IBSI-standardized radiomics features were extracted via PyRadiomics 3.1, then systematically combined with 48 dimensionality reduction algorithms and 25 classifiers into 1200 pipelines, evaluated through rotational validation (training on three datasets, external testing on the fourth, repeated across rotations) incorporating five-fold cross-validation and a composite score penalizing instability via standard deviation. Cross-validation accuracies spanned 0.91–0.96, with external testing yielding 0.87 (UCSF-PDGM), 0.98 (UPENN-GB), and 0.95 (BRATS-Africa), averaging ~0.93; F1, precision, and recall remained stable (0.87–0.96), while ROC-AUC varied (0.50–0.82) due to cohort heterogeneity, with the MI + ETr pipeline ranking highest for balanced accuracy and stability. This framework enables reliable, generalizable prediction of contrast enhancement from non-contrast glioma MRI, minimizing GBCA dependence and offering a scalable template for reproducible ML in neuro-oncology.